Clinical study of valsartan combined with benazepril in the treatment of congestive heart failure
10.3969/j.issn.1005-1678.2017.07.139
- VernacularTitle:缬沙坦联合贝那普利治疗充血性心力衰竭的临床研究
- Author:
Jianqiang ZHANG
;
Bo QI
- Keywords:
congestive heart failure;
benazepril;
valsartan;
cardiac function
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(7):337-338,341
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the therapeutic values of valsartan combined with benazepril in the treatment of patients with congestive heart failure.Methods 102 cases of patients with congestive heart failure in Nine 0 Third Hospital were enrolled in the study.They were randomly divided into the control group and the observation group, with 51 cases in each group.Both groups were given cardiac diuretic, anti-infection and other basic treatment and the control group was given benazepril on the basis of basic treatment while the observation group was additionally given valsartan on the basis of treatment in the control group.The curative effects were compared and the changes of cardiac function indexes were detected before and after treatment between the two groups.Results The effective rate of treatment was 80.39% in the control group, which was lower than that in the observation group with 96.08% (P<0.05).After treatment, the observation group LVEF increased significantly, LVESd and LVEDd decreased significantly, and each index was significantly better than that of the control group (P<0.05).Conclusion Valsartan combined with benazepril in the treatment of congestive heart failure can effectively relieve the clinical symptoms and improve the cardiac function, therefore it is worthy of clinical promotion.
